Skip to main content
SpringerLink
Log in

Kein besseres Überleben durch adjuvante Chemotherapie bei lymphknotennegativem Rektumkarzinom nach Radiochemotherapie

No improved survival with adjuvant chemotherapy in node negative rectal cancer after radiochemotherapy

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Fietkau R, Barten M, Klautke G et al (2006) Postoperative chemotherapy may not be necessary for patiets with ypN0-category after neoadjuvant chemoradiotherapy of rectal cancer. Dis Colon Rectum 49:1284–1292

    Article  PubMed  Google Scholar 

  2. Fietkau R, Klautke G (2008) Adjuvant chemotherapy following neoadjuvant therapy of rectal cancer: the type of neoadjuvant therapy (chemoradiotherapy or radiotherapy) may be important for selection of patients. J Clin Oncol 26:507–508

    Article  PubMed  Google Scholar 

  3. Glynne-Jones R, Kadalayil L, Meadows HM et al (2014) Chronicle: results of a randomized phase III trial in locally advanced rectal cancer after neoadjuvant chemoradation randomizing postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control. Ann Oncol 25:1356–1362

    Article  CAS  PubMed  Google Scholar 

  4. Hong YS, Nam BH, Kim KP et al (2014) Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy fpr locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicenter, phase2, randomized controlled trial. Lancet Oncol 15:1245–1253

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Radioonkologie, Städtisches Klinikum Chemnitz gGmbH, Flemmingstraße 2, 09116, Chemnitz, Deutschland

    Gunther Klautke

Authors
  1. Gunther Klautke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gunther Klautke.

Ethics declarations

Interessenkonflikt

G. Klautke gibt an, dass kein Interessenkonflikt besteht.

Additional information

Originalpublikation Baird DLH, Denost Q, Simillis C et al (2017) The role of adjuvant chemotherapy on survival and recurrence after curative rectal cancer surgery on patients who are histologically node negative after neoadjuvant chemoradiotherapy. Colorectal Dis. https://doi.org/10.1111/codi.13714 (Epub ahead of print)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Klautke, G. Kein besseres Überleben durch adjuvante Chemotherapie bei lymphknotennegativem Rektumkarzinom nach Radiochemotherapie. Strahlenther Onkol 193, 1072–1073 (2017). https://doi.org/10.1007/s00066-017-1208-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-017-1208-8

Search

Navigation